# FDA recall D-0001-2018

> **Pfizer Inc.** · Class III · drug recall initiated 2017-07-12.

## Product

Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.

## Reason for recall

CGMP Deviations: Firm failed to control impurity for color change at the API stage.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0001-2018
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-07-12
- **Report date:** 2017-10-11
- **Termination date:** 2020-07-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0001-2018

## Citation

> AI Analytics. FDA recall D-0001-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0001-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*